Given the lack of METΔex14 cell lines available, we expanded our analysis to include publicly available RNA-seq data [12] from tumours with either high-grade wildtype MET amplification (n = 6) or METΔex14 mutations (n = 8). This evidence concerns the gene MET and neoplasm.